Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/000230 stock hub

KRX/000230 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/000230is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

101.7B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/000230

In the news

Latest news · KRX/000230

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E11.8

P25 12P50 23.1P75 39.5

ROE6.3

P25 -17.1P50 0.7P75 8.5

ROIC1.7

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/000230 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

225

Groups with data

Currency

KRW

Showing 225 of 225 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	72
Enterprise value	KRW 406.2B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7000230003
Last refreshed	2026-05-10
Market cap	KRW 101.7B
Price	KRW 9,010
Price currency	KRW
Rev Per Employee	8,206,799,255.56x
Sector	Healthcare
Sic	2834
Symbol	krx/000230
Website	https://www.ildongholdings.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	10.74%
EV Earnings	37.18x
EV/EBIT	11.35x
EV/EBITDA	6.24x
EV/FCF	31.66x
EV/Sales	0.69x
FCF yield	12.61%
P/B ratio	0.29x
P/E ratio	11.82x
P/S ratio	0.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.06%
EBITDA Margin	7.02%
FCF margin	2.17%
Gross margin	38.06%
Gross Profit	KRW 224.9B
Gross Profit Growth	-0.6%
Gross Profit Growth Q	0.31%
Gross Profit Growth3 Y	-1.98%
Gross Profit Growth5 Y	-1.79%
Net Income	KRW 10.9B
Net Income Growth	-82.67%
Net Income Growth Q	-74.62%
Net Income Growth Years	0%
Pretax Margin	5.13%
Profit Margin	1.85%
Profit Per Employee	KRW 151.7M
Profitable Years	2
ROA	0.92
Roa5y	-3.58
ROCE	2.47
ROE	6.29
Roe5y	-34.39
ROIC	1.66
Roic5y	-13.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.91%
Cagr15y	12.34%
Cagr1y	50.39%
Cagr20y	10.87%
Cagr3y	-10.39%
Cagr5y	-8.66%
Div CAGR10	-9.53%
Div CAGR3	0%
Div CAGR5	0%
EPS Growth	-80.9
EPS Growth Q	-62.47
EPS Growth Years	0
FCF Growth	102.26%
OCF Growth	55.16%
OCF Growth10 Y	-7.1%
OCF Growth5 Y	26.66%
Revenue Growth	-6.9x
Revenue Growth Q	-4.14x
Revenue Growth Years	0x
Revenue Growth3 Y	-4.36x
Revenue Growth5 Y	-0.19x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.71
Assets	KRW 802.9B
Cash	KRW 77.8B
Current Assets	KRW 242.6B
Current Liabilities	KRW 311B
Debt	KRW 199.5B
Debt EBITDA	KRW 4.81
Debt Equity	KRW 0.57
Debt FCF	KRW 15.55
Equity	KRW 351.5B
Interest Coverage	0.52
Liabilities	KRW 451.4B
Long Term Assets	KRW 560.3B
Long Term Liabilities	KRW 140.4B
Net Cash	KRW -121.7B
Net Cash By Market Cap	KRW -120
Net Debt EBITDA	KRW 2.93
Net Debt Equity	KRW 0.35
Net Debt FCF	KRW 9.49
Tangible Book Value	KRW 96.2B
Tangible Book Value Per Share	KRW 8,498
WACC	6.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.78
Inventory Turnover	3.69
Net Working Capital	KRW 46.7B
Quick ratio	0.43
Working Capital	KRW -68.5B
Working Capital Turnover	KRW -7.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	9.26%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	KRW 100
Dividend Years	1
Dividend Yield	1.11%
Ex Div Date	2026-03-30
Last Dividend	KRW 100
Payout Ratio	0.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	61.45%
1Y total return	50.35%
200-day SMA	10,825.1
3Y total return	-28.06%
50-day SMA	10,265
50-day SMA vs 200-day SMA	50under200
5Y total return	-36.4%
All Time High	59,200
All Time High Change	-84.78%
All Time High Date	2022-04-22
All Time Low	299.4
All Time Low Change	2,908.88%
All Time Low Date	1998-09-29
ATR	400.8
Beta	0.32
Beta1y	-0.16
Beta2y	0.36
Ch YTD	-32.2
High	9,160
High52	17,170
High52 Date	2025-12-11
High52ch	-47.52%
Low	8,710
Low52	5,890
Low52 Date	2025-05-16
Low52ch	52.97%
Ma50ch	-12.23%
Price vs 200-day SMA	-16.77%
RSI	28.65
RSI Monthly	46.89
RSI Weekly	37.83
Sharpe ratio	0.81x
Sortino ratio	1.85
Total Return	10.36%
Tr YTD	-31.56
Tr15y	472.55%
Tr1m	-7.87%
Tr1w	-7.87%
Tr3m	-19.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 12.1B
Operating Income Growth Q	35.37
Operating margin	2.06

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,736,956%
Net Borrowing	-73,231,105,440
Shares Insiders	22.93%
Shares Institutions	7.51%
Shares Out	11,292,090
Shares Qo Q	0.22%
Shares Yo Y	-9.26%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 12.5B
Average Volume	35,611.75x
Bv Per Share	14,911.6
CAPEX	KRW -14B
Ch10y	-63
Ch15y	21.29
Ch1m	-7.87
Ch1w	-7.87
Ch1y	48.93
Ch20y	50.8
Ch3m	-20.41
Ch3y	-29.44
Ch5y	-38.29
Ch6m	-32.91
Change	-0.22%
Change From Open	-0.22
Close	9,030
Days Gap	0
Depreciation Amortization	29,340,290,000
Dollar Volume	283,364,500
Earnings Date	2026-05-13
EBIT	KRW 12.1B
EBITDA	KRW 41.5B
EPS	KRW 967
F Score	7
FCF	KRW 12.8B
FCF EV Yield	3.16x
FCF Per Share	KRW 1,136
Financing CF	-50,589,412,030
Fiscal Year End	December
Founded	1,941
Goodwill	35,251,138,000
Graham Number	18012.20243
Graham Upside	99.91
Income Tax	KRW 11.1B
Investing CF	21,144,375,640
Is Primary Listing	1
Last Earnings Date	2026-02-06
Last Report Date	2025-12-31
Last Split Date	2020-03-05
Last Split Type	Forward
Ma150	11,461.7
Ma150ch	-21.39%
Ma20	9,910
Ma20ch	-9.08%
Net CF	-2,676,591,590
Next Earnings Date	2026-05-13
Open	9,030
P FCF Ratio	7.93
P OCF Ratio	3.79
Payment Date	2026-04-24
Position In Range	66.67
Ppne	321,448,933,710
Price Date	2026-05-08
Price EBITDA	KRW 2.45
Ptbv Ratio	1.06
Relative Volume	0.9x
Revenue	590,889,546,400x
SBC By Revenue	0.05x
Share Based Comp	320,540,000
Tax By Revenue	1.87x
Tax Rate	36.47%
Tr20y	687.32%
Tr6m	-32.27%
Volume	31,450
Z Score	0.56

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/000230 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$100 annual per share

Payout ratio

+0.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

+10.4%

Next ex-dividend date: 2026-03-30

Performance

KRX/000230 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/000230?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.5%

Share of float held by funds and institutions

Insider ownership

+22.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-9.3%

Negative means the company is buying back shares.

Technical

KRX/000230 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

28.6

Below 30: short-term oversold

Price vs 200-day MA

-16.8%

50/200-day relationship not available

Beta (5Y)

0.32

Less volatile than the market

Sharpe ratio

0.81

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/000230

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/000230 stock rating?

krx/000230 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/000230 analysis?

The full report lives at /stocks/krx/000230/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/000230?

The latest report frames krx/000230 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/000230 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.